|
1
|
O'Brien H, Mohan H, Hare C, Reynolds J and
Kenn R: Mind over matter? The hidden epidemic of cognitive
dysfunction in the older surgical patient. Ann Surg. 265:677–691.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Skvarc D, Berk M, Byrne L, Dean O, Dodd S,
Lewis M, Marriott A, Moore EM, Morris G, Page RS and Gray L:
Post-operative cognitive dysfunction: An exploration of the
inflammatory hypothesis and novel therapies. Neurosci Biobehav Rev.
84:116–133. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kulason K, Nouchi R, Hoshikawa Y, Noda M,
Okada Y and Kawashima R: Indication of cognitive change and
associated risk factor after thoracic surgery in the elderly: A
pilot study. Front Aging Neurosci. 9:3962017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schenning KJ, Murchison CF, Mattek NC,
Kaye JA and Quinn JF: Sex and genetic differences in postoperative
cognitive dysfunction: A longitudinal cohort analysis. Biol Sex
Differ. 10:142019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Boodhwani M, Rubens FD, Wozny D, Rodriguez
R, Alsefaou A, Hendry PJ and Nathan HJ: Predictors of early
neurocognitive deficits in low-risk patients undergoing on-pump
coronary artery bypass surgery. Circulation. 114:I461–I466. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu YH, Wang DX, Li LH, Wu XM, Shan GJ, Su
Y, Li J, Yu QJ, Shi CX, Huang YN and Sun W: The effects of
cardiopulmonary bypass on the number of cerebral microemboli and
the incidence of cognitive dysfunction after coronary artery bypass
graft surgery. Anesth Analg. 109:1013–1022. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bishawi M, Hattler B, Almassi GH, Spertus
JA, Quin JA, Collins JF, Grover FL and Shroyer AL: Preoperative
factors associated with worsening in health-related quality of life
following coronary artery bypass grafting in the Randomized On/Off
Bypass (ROOBY) trial. Am Heart J. 198:33–38. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Needham MJ, Webb CE and Bryden DC:
Postoperative cognitive dysfunction and dementia: What we need to
know and do. Br J Anaesth. 119:i115–i125. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rundshagen I: Postoperative cognitive
dysfunction. Dtsch Arztebl Int. 111:119–125. 2014.PubMed/NCBI
|
|
10
|
Silva FP, Schmidt AP, Valentin LS, Pinto
KO, Zeferino SP, Oses JP, Wiener CD, Otsuki DA, Tort AB, Portela
LV, et al: S100B protein and neuron-specific enolase as predictors
of cognitive dysfunction after coronary artery bypass graft
surgery: A prospective observational study. Eur J Anaesthesiol.
33:681–689. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Deng L, Liu G, Zheng C, Zhang L, Kang Y
and Yang F: Circ-LAMP1 promotes T-cell lymphoblastic lymphoma
progression via acting as a ceRNA for miR-615-5p to regulate DDR2
expression. Gene. 701:146–151. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hanan M, Soreq H and Kadener S: CircRNAs
in the brain. RNA Biol. 14:1028–1034. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu C, Yao M, Li C, Shan K, Yang H, Wang
J, Liu B, Li XM, Yao J, Jiang Q and Yan B: Silencing Of circular
RNA-ZNF609 ameliorates vascular endothelial dysfunction.
Theranostics. 7:2863–2877. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Han B, Chao J and Yao H: Circular RNA and
its mechanisms in disease: From the bench to the clinic. Pharmacol
Ther. 187:31–44. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Floris G, Zhang L, Follesa P and Sun T:
Regulatory role of circular RNAs and neurological disorders. Mol
Neurobiol. 54:5156–5165. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li S, Li Y, Chen B, Zhao J, Yu S, Tang Y,
Zheng Q, Li Y, Wang P, He X and Huang S: ExoRBase: A database of
circRNA, lncRNA and mRNA in human blood exosomes. Nucleic Acids
Res. 46:D106–D112. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Otero-Ortega L, Laso-García F, Gómez-de
Frutos M, Fuentes B, Diekhorst L, Díez-Tejedor E and
Gutiérrez-Fernández M: Role of exosomes as a treatment and
potential biomarker for stroke. Transl Stroke Res. 10:241–249.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li X, Zhang S, Zhang J, Zhu J, He H, Zhang
Y, Zhang W and Tian D: Construct validity and reliability of the
test your memory chinese version in older neurology outpatient
attendees. Int J Ment Health Syst. 12:642018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Seo EH, Lee DY, Choo IH, Kim SG, Kim KW,
Youn JC, Jhoo JH and Woo JI: Normative study of the stroop color
and word test in an educationally diverse elderly population. Int J
Geriatr Psychiatry. 23:1020–1027. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Płotek W, Łyskawa W, Kluzik A, Grześkowiak
M, Podlewski R, Żaba Z and Drobnik L: Evaluation of the trail
making test and interval timing as measures of cognition in healthy
adults: Comparisons by age, education, and gender. Med Sci Monit.
20:173–181. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Forn C, Belloch V, Bustamante JC, Garbin
G, Parcet-Ibars MA, Sanjuan A, Ventura N and Avila C: A symbol
digit modalities test version suitable for functional MRI studies.
Neurosci Lett. 456:11–14. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Geffen GM, Butterworth P and Geffen LB:
Test-retest reliability of a new form of the auditory verbal
learning test (AVLT). Arch Clin Neuropsychol. 9:303–316. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Benedict RH, DeLuca J, Phillips G, LaRocca
N, Hudson LD and Rudick R; Multiple Sclerosis Outcome Assessments
Consortium, : Validity of the symbol digit modalities test as a
cognition performance outcome measure for multiple sclerosis. Mult
Scler. 23:721–733. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
The Criteria Committee of the New York
Heart Association, . Nomenclature and criteria for diagnosis of
diseases of the heart and great vessels. Dolgin M: 9th. Little,
Brown & Co; Boston: pp. 253–256. 1994
|
|
25
|
Li W, Freudenberg J, Suh YJ and Yang Y:
Using volcano plots and regularized-chi statistics in genetic
association studies. Comput Biol Chem. 48:77–83. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gilman S: Cerebral disorders after
open-heart operations. N Engl J Med. 272:489–498. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nijs K, Vandenbrande J, Vaqueriza F, Ory
JP, Yilmaz A, Starinieri P, Dubois J, Jamaer L, Arijs I and Stessel
B: Neurological outcome after minimal invasive coronary artery
surgery (NOMICS): Protocol for an observational prospective cohort
study. BMJ Open. 7:e0178232017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cascella M and Bimonte S: The role of
general anesthetics and the mechanisms of hippocampal and
extra-hippocampal dysfunctions in the genesis of postoperative
cognitive dysfunction. Neural Regen Res. 12:1780–1785. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jeck WR, Sorrentino JA, Wang K, Slevin MK,
Burd CE, Liu J, Marzluff WF and Sharpless NE: Circular RNAs are
abundant, conserved, and associated with ALU repeats. RNA.
19:141–157. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Van Rossum D, Verheijen BM and Pasterkamp
RJ: Circular RNAs: Novel regulators of neuronal development. Front
Mol Neurosci. 9:742016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tay Y, Rinn J and Pandolfi PP: The
multilayered complexity of ceRNA crosstalk and competition. Nature.
505:344–352. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ji MH, Yuan HM, Zhang GF, Li XM, Dong L,
Li WY, Zhou ZQ and Yang JJ: Changes in plasma and cerebrospinal
fluid biomarkers in aged patients with early postoperative
cognitive dysfunction following total hip-replacement surgery. J
Anesth. 27:236–242. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Iranifar E, Seresht BM, Momeni F, Fadaei
E, Mehr MH, Ebrahimi Z, Rahmati M, Kharazinejad E and Mirzaei H:
Exosomes and microRNAs: New potential therapeutic candidates in
alzheimer disease therapy. J Cell Physiol. 234:2296–2305. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Frühbeis C, Fröhlich D, Kuo WP, Amphornrat
J, Thilemann S, Saab AS, Kirchhoff F, Möbius W, Goebbels S, Nave
KA, et al: Neurotransmitter-triggered transfer of exosomes mediates
oligodendrocyte-neuron communication. PLoS Biol. 11:e10016042013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang TT, Liu CG, Gao SC, Zhang Y and Wang
PC: The serum exosome derived microRNA-135a, −193b, and −384 were
potential alzheimer's disease biomarkers. Biomed Environ Sci.
31:87–96. 2018.PubMed/NCBI
|
|
36
|
Ding M, Shen Y, Wang P, Xie Z, Xu S, Zhu
Z, Wang Y, Lyu Y, Wang D and Xu L: Exosomes isolated from human
umbilical cord mesenchymal stem cells alleviate neuroinflammation
and reduce amyloid-beta deposition by modulating microglial
activation in alzheimer's disease. Neurochem Res. 43:2165–2177.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou M, Wang MH, Wang XB, Liu KZ, Wan YQ,
Li M, Liu L and Zhang C: Abnormal expression of microRNAs induced
by chronic unpredictable mild stress in rat hippocampal tissues.
Mol Neurobiol. 55:917–913. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Barucker C, Sommer A, Beckmann G, Eravci
M, Harmeier A, Schipke CG, Brockschnieder D, Dyrks T, Althoff V,
Fraser PE, et al: Alzheimer amyloid peptide aβ42 regulates gene
expression of transcription and growth factors. J Alzheimers Dis.
44:613–624. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fernandes J, Vieira AS, Kramer-Soares JC,
Da Silva EA, Lee KS, Lopes-Cendes I and Arida RM: Hippocampal
microRNA-mRNA regulatory network is affected by physical exercise.
Biochim Biophys Acta Gen Subj. 1862:1711–1720. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jing XP, Peng QH, Hu R, Zou HW, Wang HZ,
Yu XQ, Zhou JW, Degen A and Wang ZS: Dietary supplements during the
cold season increase rumen microbial abundance and improve rumen
epithelium development in tibetan sheep. J Anim Sci. 96:293–305.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Shahim P, Blennow K, Johansson P, Svensson
J, Lista S, Hampel H, Andersson LC and Zetterberg H: Cerebrospinal
fluid stanniocalcin-1 as a biomarker for alzheimer's disease and
other neurodegenerative disorders. Neuromolecular Med. 19:154–160.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ramocki MB, Bartnik M, Szafranski P,
Kolodziejska KE, Xia Z, Bravo J, Miller GS, Rodriguez DL, Williams
CA, Bader PI, et al: Recurrent distal 7q11.23 deletion including
HIP1 and YWHAG identified in patients with intellectual
disabilities, epilepsy, and neurobehavioral problems. Am J Hum
Genet. 87:857–865. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Noel A, Ingrand S and Barrier L:
Inhibition of GSK3β by pharmacological modulation of sphingolipid
metabolism occurs independently of ganglioside disturbance in a
cellular model of Alzheimer's disease. Exp Neurol. 271:308–318.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mielke MM and Lyketsos CG: Alterations of
the sphingolipid pathway in Alzheimer's disease: New biomarkers and
treatment targets? Neuromolecular Med. 12:331–340. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ariga T, Jarvis WD and Yu RK: Role of
sphingolipid-mediated cell death in neurodegenerative diseases. J
Lipid Res. 39:1–16. 1998.PubMed/NCBI
|
|
46
|
Wang X, Wang Z, Chen Y, Huang X, Hu Y,
Zhang R, Ho MS and Xue L: FoxO mediates APP-induced AICD-dependent
cell death. Cell Death Dis. 5:e12332014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Qin L, Chong T, Rodriguez R and
Pugazhenthi S: Glucagon-like peptide-1-mediated modulation of
inflammatory pathways in the diabetic brain: Relevance to
alzheimer's disease. Current Alzheimer Res. 13:1346–1355. 2016.
View Article : Google Scholar
|
|
48
|
Tramutola A, Arena A, Cini C, Butterfield
DA and Barone E: Modulation of GLP-1 signaling as a novel
therapeutic approach in the treatment of Alzheimer's disease
pathology. Expert Rev Neurother. 17:59–75. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wang Y, Chen S, Xu Z, Chen S, Yao W and
Gao X: GLP-1 receptor agonists downregulate aberrant GnT-III
expression in Alzheimer's disease models through the
Akt/GSK-3β/β-catenin signaling. Neuropharmacology. 131:190–199.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
An FM, Chen S, Xu Z, Yin L, Wang Y, Liu
AR, Yao WB and Gao XD: Glucagon-like peptide-1 regulates
mitochondrial biogenesis and tau phosphorylation against advanced
glycation end product-induced neuronal insult: Studies in vivo and
in vitro. Neuroscience. 300:75–84. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang N, Li L, Li Z, Ni C, Cao Y, Liu T,
Tian M, Chui D and Guo X: Protective effect of dapsone on cognitive
impairment induced by propofol involves hippocampal autophagy.
Neuroscience Lett. 649:85–92. 2017. View Article : Google Scholar
|
